REBECCA MANGALI: Open Payments
NPI 1225327042 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,161 in 11 payments from 7 companies in 2025. Trend: 2023 $601 · 2024 $1,468 · 2025 $1,161
Food & beverage: $1,161
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 4 | $390 |
| COLOPLAST CORP | 2 | $197 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Neurocrine BioSciences, Inc. | 1 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $124 |
| Medtronic, Inc. | 1 | $94 |
| GENZYME CORPORATION | 1 | $77 |
Products named: Titan, REZDIFFRA, INGREZZA, Kerendia, CLOSUREFAST.
Industry payments across FL — which companies pay providers there.
